EPISODE · Feb 28, 2026 · 2 MIN
**Ozempic Weightloss Unlocked: Medical Breakthroughs and Real Health Impacts**
from Ozempic Weightloss Unlocked · host Inception Point AI
Welcome to Ozempic Weightloss Unlocked, where we dive into the latest on Ozempic from medical breakthroughs to real-life health impacts. Listeners, exciting news from Novo Nordisk: oral semaglutide at 25 milligrams, branded as Wegovy in pill form, delivered 16.6 percent weight loss in a newly published study. Apollo Pharmacy reports clinical trials showing average weight loss of 10 to 15 percent of body weight with semaglutide, and up to 20 to 22 percent with tirzepatide in some patients. The OASIS 4 Study Group in the New England Journal of Medicine found oral semaglutide 25 milligrams daily for 64 weeks led to about 11 percent more weight loss than placebo, around 26 pounds for a 234-pound person. According to the 2026 American Diabetes Association Standards of Care, preferred treatments for diabetes with overweight or obesity include glucagon-like peptide-1 receptor agonists like semaglutide or dual agonists like tirzepatide for their superior weight loss, cardiovascular, and metabolic benefits. These drugs suppress appetite, delay gastric emptying, and improve insulin sensitivity, mimicking bariatric surgery effects. Real-world data from HealthDay News and Epocrates shows satisfaction with semaglutide is driven by effective weight loss, with two-thirds of users reporting reduced appetite, cravings, or body weight, even though gastrointestinal side effects like nausea affect many. Rare concerns include motility disorders, but efficacy often outweighs them. A key caution from the STEP 1 trial extension in Diabetes Obesity and Metabolism: stopping semaglutide leads to significant regain, over 11 percentage points of lost weight by 120 weeks, as food noise returns. Physicians Committee for Responsible Medicine notes many regain two-thirds within a year, stressing long-term use or lifestyle transitions like daily habits to quiet cravings naturally. Oral Wegovy must be swallowed whole with no more than four ounces of water, 30 minutes before food or other meds, for full effect. It costs about 1350 dollars monthly, with prior authorizations likely. Stay tuned for more updates on these game-changers in weight management and health. Thank you listeners for tuning in. Please subscribe for weekly insights. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI.
What this episode covers
Welcome to Ozempic Weightloss Unlocked, where we dive into the latest on Ozempic from medical breakthroughs to real-life health impacts. Listeners, exciting news from Novo Nordisk: oral semaglutide at 25 milligrams, branded as Wegovy in pill form, delivered 16.6 percent weight loss in a newly published study. Apollo Pharmacy reports clinical trials showing average weight loss of 10 to 15 percent of body weight with semaglutide, and up to 20 to 22 percent with tirzepatide in some patients. The OASIS 4 Study Group in the New England Journal of Medicine found oral semaglutide 25 milligrams daily for 64 weeks led to about 11 percent more weight loss than placebo, around 26 pounds for a 234-pound person. According to the 2026 American Diabetes Association Standards of Care, preferred treatments for diabetes with overweight or obesity include glucagon-like peptide-1 receptor agonists like semaglutide or dual agonists like tirzepatide for their superior weight loss, cardiovascular, and metabolic benefits. These drugs suppress appetite, delay gastric emptying, and improve insulin sensitivity, mimicking bariatric surgery effects. Real-world data from HealthDay News and Epocrates shows satisfaction with semaglutide is driven by effective weight loss, with two-thirds of users reporting reduced appetite, cravings, or body weight, even though gastrointestinal side effects like nausea affect many. Rare concerns include motility disorders, but efficacy often outweighs them. A key caution from the STEP 1 trial extension in Diabetes Obesity and Metabolism: stopping semaglutide leads to significant regain, over 11 percentage points of lost weight by 120 weeks, as food noise returns. Physicians Committee for Responsible Medicine notes many regain two-thirds within a year, stressing long-term use or lifestyle transitions like daily habits to quiet cravings naturally. Oral Wegovy must be swallowed whole with no more than four ounces of water, 30 minutes before food or other meds, for full effect. It costs about 1350 dollars monthly, with prior authorizations likely. Stay tuned for more updates on these game-changers in weight management and health. Thank you listeners for tuning in. Please subscribe for weekly insights. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI.
NOW PLAYING
**Ozempic Weightloss Unlocked: Medical Breakthroughs and Real Health Impacts**
No transcript for this episode yet
Similar Episodes
Jun 25, 2026 ·58m
Jun 18, 2026 ·85m
Jun 18, 2026 ·115m
Jun 16, 2026 ·74m
Jun 7, 2026 ·69m